Related Experiment Video
Updated: Mar 14, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12.8K
Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome
Robert E Heinl1, Devinder S Dhindsa1, Elliot N Mahlof1
1Division of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
The Canadian Journal of Cardiology
|October 4, 2016
Summary
Obesity drives metabolic syndrome (MetS) and diabetes (DM), increasing cardiovascular risk. Innovative cardiac rehabilitation (CR) models are needed to improve CR access and outcomes for these high-risk patients.
Area of Science:
- Cardiology
- Metabolic Diseases
- Public Health
Background:
- Obesity is a global epidemic, driving metabolic syndrome (MetS) and diabetes mellitus (DM).
- MetS and DM significantly increase cardiovascular morbidity and mortality.
- Healthy lifestyle changes are crucial for managing atherosclerotic cardiovascular disease in these populations.
Purpose of the Study:
- To highlight the benefits of cardiac rehabilitation (CR) for patients with MetS and DM.
- To identify barriers preventing MetS and DM patients from attending and completing CR.
- To propose innovative CR delivery models to improve access and outcomes.
Main Methods:
- Literature review on MetS, DM, cardiovascular disease, and cardiac rehabilitation.
- Analysis of factors influencing CR participation in high-risk populations.
- Exploration of novel CR delivery strategies.
Main Results:
- Comprehensive CR reduces mortality and hospitalizations in MetS and DM patients.
- Patients with MetS and DM face significant barriers to CR attendance and completion.
- Innovative CR models show potential for improved utilization and outcomes.
Conclusions:
- Cardiac rehabilitation is vital for managing cardiovascular risk in MetS and DM.
- Addressing barriers to CR is essential for this patient group.
- Novel CR delivery models may enhance CR uptake and improve cardiovascular health.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
01:26Atherosclerosis III: Management
558
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
558
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:26Coronary Artery Disease IV: Preventive Measures
794
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
794
01:29Cardiomyopathy V: Interprofessional Care
574
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
01:27Coronary Artery Disease V: Interprofessional Care
359
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359